radiosynthesis of [103pd]-di-actyl-bis (n4-methylthiosemicarbazone): a potential therapeutic agent
Authors
abstract
background: due to interesting tumor imaging properties of bis-thiosemicarbazones, [103pd]-di-acetyl-bis (n4-methylthiosemicarbazone) ([103pd] atsm2) was prepared according to the analogy of radio copper homologues. materials and methods: palladium-103 (t1/2=16.96 d) was produced via the 103rh (p,n) 103pd nuclear reaction with proton energy 18 mev. the final activity was eluted in form of pd (nh4)2cl2 in order to react with bis-thiosemicarbazones to yield [103pd]-labeled compounds. chemical purity of the final product was confirmed to be below the accepted limits by polarography. the labeled compound was purified by reverse phase column chromatography using c18 plus sep-pak. the partition co-efficient of the final complexes were determined. the initial physico-chemical properties of the labeled compounds were compared to those of their copper homologues. results: radiochemical purity of more than 99% using rtlc was obtained (specific activity of about 12500-13000 ci/mol). the stability of the tracer was checked in final product and human serum, at 37c up to 48h. conclusion: the labeled compound prepared in this study is probably one of the few new 103pd-radiolabeled compounds which have a potential for future biological studies, regarding its suitable physicochemical stability.
similar resources
Radiosynthesis of [103Pd]-di-actyl-bis (N4-methylthiosemicarbazone): a potential therapeutic agent
Background: Due to interesting tumor imaging properties of bis-thiosemicarbazones, [103Pd]-di-acetyl-bis (N4-methylthiosemicarbazone) ([103Pd] ATSM2) was prepared according to the analogy of radio copper homologues. Materials and Methods: Palladium-103 (T1/2=16.96 d) was produced via the 103Rh (p,n) 103Pd nuclear reaction with proton energy 18 MeV. The final activity was eluted in form of Pd ...
full textCopper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.
Systemic administration of hypoxia-selective (64)Cu-diacetyl-bis(N(4)-methylthiosemicarbazone) ((64)Cu-ATSM) has increased significantly the survival time of hamsters bearing human GW39 colon cancer tumors. Radiotherapy experiments were performed in animals bearing either 7-day-old (0.5-1.0 g) or 15-day-old (1.5-2.0 g) tumors. Studies compared animals treated with a single dose of 0, 4, 6, 7, 8...
full textPreparation of [64Cu] Pyruvaldehyde-bis (N4-methylthiosemicarbazone) complex as a PET and/or therapeutic radiopharmaceutical
Background: Copper-64 (T1/2=12.7 h) is an important radionuclide used both in PET imaging and therapy. [64Cu]-pyruvaldehyde-bis (N4-methylthiosemicarbazone) ([64Cu]-PTSM) is one of the most famous copper radiopharmaceuticals with unique specifications (suitable half life, stability, etc.). The wide range of 64Cu applications arouse great interest for its production. Materials and Methods: Cu-64...
full textIntertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
UNLABELLED Cu-Diacetyl-bis(N(4)-methylthiosemicarbazone) (Cu-ATSM) is a recently developed PET imaging agent for tumor hypoxia. However, its accuracy and reliability for measuring hypoxia have not been fully characterized in vivo. The aim of this study was to evaluate (64)Cu-ATSM as a hypoxia PET marker by comparing autoradiographic distributions of (64)Cu-ATSM with a well-established hypoxia m...
full textpreparation of [64cu] pyruvaldehyde-bis (n4-methylthiosemicarbazone) complex as a pet and/or therapeutic radiopharmaceutical
background: copper-64 (t1/2=12.7 h) is an important radionuclide used both in pet imaging and therapy. [64cu]-pyruvaldehyde-bis (n4-methylthiosemicarbazone) ([64cu]-ptsm) is one of the most famous copper radiopharmaceuticals with unique specifications (suitable half life, stability, etc.). the wide range of 64cu applications arouse great interest for its production. materials and methods: cu-64...
full textBiodistribution of [64Cu]pyruvaldehyde-bis (N4-methylthiosemicarbazone) complex in fibrosarcoma-bearing rats [Persian]
Introduction: 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (64Cu-PTSM) is one of the most important copper radiopharmaceuticals used in clinical experiments. Methods: In this work, copper-64 (T1/2=12.33 h) production has been presented followed by the synthesis of the complexing agent, PTSM, and its structure was confirmed by common spectroscopic methods followed by radiolabeling w...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of radiation researchجلد ۴، شماره ۱، صفحات ۴۱-۴۸
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023